non-glp-1 medications Obesity care isn't one-drug-fits-all. ​ Obesity management is evolving beyond GLP-1 medications. ​ This session explores personalized approaches that improve outcomes across diverse patient populations. ​ Learn how non- GLP-1 therapies can support TrimRX | GLP-1 vs GIP:

These microbial changes significantly enhance GLP-1 activity (Xu et al., 2019)

Culinary medicine and culinary nutrition education for individuals with the capacity to influence health related behaviour change: a scoping review

These low doses are designed to help your body adjust safely and minimise gastrointestinal side effects

A low glycemic index diet does not affect postprandial energy metabolism but decreases postprandial insulinemia and increases fullness ratings in healthy women

262,263 GLP-1 regulates energy balance and food intake by acting on specific brain regions, especially the hypothalamus, a key area responsible for hunger and fullness sensations

Adenosine triphosphate is co-secreted with glucagon-like peptide-1 to modulate intestinal enterocytes and afferent neurons